Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Tianyin Boosts Stock Price with Buyback

publication date: Oct 28, 2008

Tianyin Pharmaceutical announced that it would spend $3 million of its $12.1 million in cash to buy back its own shares. Management said the company is cash-flow positive, and it has enough cash, even with the buyback, to finish construction of its solid-dose manufacturing plant without raising additional capital. The announcement provided a huge boost for Tianyin’s share price. Its stock, which recently migrated to the AMEX, jumped 54 cents to $1.74, a 45% increase. More details...

Stock Symbol: (AMEX: TPI)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital